235 related articles for article (PubMed ID: 35550840)
1. LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson's disease by regulating the miR-223-3p/NRP1 axis.
Liu L; Zhou T; Li T; Liang Z; Luo X
Behav Brain Res; 2022 Aug; 431():113923. PubMed ID: 35550840
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of LncRNA DLX6-AS1 inhibits HK-2 cell pyroptosis via regulating miR-223-3p/NLRP3 pathway in lipopolysaccharide-induced acute kidney injury.
Tan J; Fan J; He J; Zhao L; Tang H
J Bioenerg Biomembr; 2020 Oct; 52(5):367-376. PubMed ID: 32666494
[TBL] [Abstract][Full Text] [Related]
3. LncRNA miR-17-92a-1 cluster host gene (MIR17HG) promotes neuronal damage and microglial activation by targeting the microRNA-153-3p/alpha-synuclein axis in Parkinson's disease.
Zhang J; Yang Y; Zhou C; Zhu R; Xiao X; Zhou B; Wan D
Bioengineered; 2022 Feb; 13(2):4493-4516. PubMed ID: 35137671
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA GAS5 promotes microglial inflammatory response in Parkinson's disease by regulating NLRP3 pathway through sponging miR-223-3p.
Xu W; Zhang L; Geng Y; Liu Y; Zhang N
Int Immunopharmacol; 2020 Aug; 85():106614. PubMed ID: 32470877
[TBL] [Abstract][Full Text] [Related]
5. Silencing long non-coding RNA DLX6-AS1 or restoring microRNA-193b-3p enhances thyroid carcinoma cell autophagy and apoptosis via depressing HOXA1.
Feng L; Wang R; Wang Y; Shen X; Shi Q; Lian M; Ma H; Fang J
J Cell Mol Med; 2021 Oct; 25(19):9319-9330. PubMed ID: 34514705
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model.
Sun Q; Wang S; Chen J; Cai H; Huang W; Zhang Y; Wang L; Xing Y
J Cell Physiol; 2019 Dec; 234(12):23379-23387. PubMed ID: 31232472
[TBL] [Abstract][Full Text] [Related]
7. LncRNA NEAT1 Regulates the Development of Parkinson's Disease by Targeting AXIN1 Via Sponging miR-212-3p.
Liu T; Zhang Y; Liu W; Zhao J
Neurochem Res; 2021 Feb; 46(2):230-240. PubMed ID: 33241432
[TBL] [Abstract][Full Text] [Related]
8. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
[TBL] [Abstract][Full Text] [Related]
9. TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson's Disease Mice and LPS-Induced BV2 Cells.
Huang P; Zhang Z; Zhang P; Feng J; Xie J; Zheng Y; Liang X; Zhu B; Chen Z; Feng S; Wang L; Lu J; Liu Y; Zhang Y
Mol Neurobiol; 2024 May; 61(5):2590-2605. PubMed ID: 37917301
[TBL] [Abstract][Full Text] [Related]
10. Regulatory mechanism of miR-20a-5p in neuronal damage and inflammation in lipopolysaccharide-induced BV2 cells and MPTP-HCl-induced Parkinson's disease mice.
Gao Y; Sheng D; Chen W
Psychogeriatrics; 2024 Apr; ():. PubMed ID: 38664198
[TBL] [Abstract][Full Text] [Related]
11. LncRNA H19 Regulates Lipopolysaccharide (LPS)-Induced Apoptosis and Inflammation of BV2 Microglia Cells Through Targeting miR-325-3p/NEUROD4 Axis.
Gu E; Pan W; Chen K; Zheng Z; Chen G; Cai P
J Mol Neurosci; 2021 Jun; 71(6):1256-1265. PubMed ID: 33205379
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson's disease.
Wang D; Gao H; Qin Q; Li J; Zhao J; Qu Y; Li J; Xiong Y; Min Z; Mao Z; Xue Z
J Transl Med; 2024 Jan; 22(1):63. PubMed ID: 38229084
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
14. Suppression of lncRNA OIP5-AS1 Attenuates Apoptosis and Inflammation, and Promotes Proliferation by Mediating miR-25-3p Expression in Lipopolysaccharide-Induced Myocardial Injury.
Ma J; Qian H; Zou H
Anal Cell Pathol (Amst); 2023; 2023():3154223. PubMed ID: 36994450
[TBL] [Abstract][Full Text] [Related]
15. LncRNA HOTAIR promotes α-synuclein aggregation and apoptosis of SH-SY5Y cells by regulating miR-221-3p in Parkinson's disease.
Sun Q; Zhang Y; Wang S; Yang F; Cai H; Xing Y; Zhou L; Chen S; Wang Y
Exp Cell Res; 2022 Aug; 417(1):113132. PubMed ID: 35398161
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.
Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G
FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872
[TBL] [Abstract][Full Text] [Related]
17. Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis.
Liu X; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X; Meng Y
Cancer Gene Ther; 2021 May; 28(5):486-501. PubMed ID: 33277615
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of long non-coding RNA HOXA11-AS against neuroinflammation in Parkinson's disease model via targeting miR-124-3p mediated FSTL1/NF-κB axis.
Cao H; Han X; Jia Y; Zhang B
Aging (Albany NY); 2021 Apr; 13(8):11455-11469. PubMed ID: 33839699
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MEG8 ameliorates Parkinson's disease neuro-inflammation through miR-485-3p/FBXO45 axis.
Lin X; Tao T; He X; Mao L; Pan L; Chen L
Acta Neurol Belg; 2024 Apr; 124(2):549-557. PubMed ID: 37814093
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA SNHG1 Promotes Neuroinflammation in Parkinson's Disease via Regulating miR-7/NLRP3 Pathway.
Cao B; Wang T; Qu Q; Kang T; Yang Q
Neuroscience; 2018 Sep; 388():118-127. PubMed ID: 30031125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
